BioCancell's business strategy is derived from its core competencies - a robust scientific and technological base, dedicated and dynamic management team and strong IP position. The Company advances its products through completion of Phase II clinical trials, while furthering their development through strategic alliances to bring them to market. Value to stockholders is achieved through royalty-generating licensing agreements.

Core Values

Scientific Stature - we are dedicated to the highest level of scientific innovation and research while maintaining the strictest standards of ethics and integrity.

Compassion - we value life and we devote our resources to its preservation and improvement.

Excellence in Execution - we set aggressive goals with confidence in our ability to perseverance in achieving them.

Creating Value - we are committed to the creation of value for the patients we serve, the societies we inhabit and the stockholders who believe in us.